GMO Strategic Opportunities Allocation Fund Class III (GBATX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.00: the stock has moved roughly in step with the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGMO Strategic Opportunities Allocation Fund Class III (GBATX) trades at $19.44. GMO Strategic Opportunities Allc III is a fund that invests primarily in other GMO Trust series, including Equity Funds, Fixed Income Funds, Implementation Funds, and Alternative Funds.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for GBATX: GBATX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
GMO Strategic Opportunities Allocation Fund Class III Company Overview
GMO Strategic Opportunities Allc III operates as a fund that strategically allocates its assets across various GMO Trust series, encompassing equity, fixed income, implementation, and alternative investment strategies. The fund employs derivatives and short selling, either directly or indirectly, to optimize portfolio performance and manage risk within the broader investment landscape.
What Is the Investment Thesis for GBATX?
GMO Strategic Opportunities Allc III presents a diversified investment vehicle through its allocation across various GMO Trust series. Key value drivers include the performance of the underlying Equity, Fixed Income, Implementation, and Alternative Funds. The fund's use of derivatives and short sales may enhance returns but also introduces potential risks. With a market capitalization of $0.09 billion and a beta of 1.00, the fund's performance is expected to align with broader market movements. Investors should monitor the performance of the underlying GMO Funds and the effectiveness of the fund's derivative and short selling strategies to assess its overall value proposition. There is no dividend yield, so returns are based on capital appreciation.
Based on FMP financials and quantitative analysis
GBATX Key Highlights
Market Cap: $0.09 billion, indicating the fund's size and relative market presence.
- Beta: 1.00, suggesting the fund's volatility is similar to the overall market.
- Investment in Underlying GMO Funds: The fund's performance is heavily reliant on the performance of the underlying GMO Trust series.
- Use of Derivatives: The fund's use of derivatives can amplify returns but also increases risk.
- No Dividend Yield: Investors should not expect income from dividends, focusing instead on potential capital appreciation.
Who Are GBATX's Competitors?
GBATX is benchmarked below against 5 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| FCIVX Frontier MFG Core Infrastructure Fund Service Class | $13.58 | -0.34% | $70.7M | — |
| FMGIX Frontier MFG Core Infrastructure Fund Institutional Class | $13.37 | -1.24% | $71.5M | — |
| IAFMX F/m Investments Large Cap Focused Fund - Investor Class | $18.65 | -2.30% | $88.8M | — |
| JSVTX Janus Henderson Small-Mid Cap Value Fund - T Shares | $16.13 | -1.77% | $65.7M | — |
| JVSIX Janus Henderson Small-Mid Cap Value Fund - I Shares | $16.33 | -1.74% | $65.7M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GBATX's Key Strengths?
Diversified exposure to various asset classes through underlying GMO Funds.
- Access to GMO's investment expertise and resources.
- Flexibility to use derivatives and short sales to enhance returns or hedge risks.
- Established track record of GMO Trust.
What Are GBATX's Weaknesses?
Performance is heavily reliant on the performance of underlying GMO Funds.
- Use of derivatives and short sales can increase risk.
- Lack of direct control over the investment decisions of underlying funds.
- No dividend yield may not appeal to income-seeking investors.
What Are the Key Risks for GBATX?
Market volatility and economic downturns impacting fund performance.
- Dependence on the performance of underlying GMO Funds.
- Increased competition from other multi-asset funds.
- Regulatory changes and compliance costs affecting fund operations.
What Threats Does GBATX Face?
- Market volatility and economic downturns can negatively impact fund performance.
- Changes in interest rates can affect the value of fixed income investments.
- Increased competition from other multi-asset funds and investment vehicles.
- Regulatory changes and compliance costs.
What Are GBATX's Competitive Advantages?
- Access to GMO's investment expertise.
- Diversified exposure across asset classes.
- Flexibility to use derivatives and short sales.
What Does GBATX Do?
GMO Strategic Opportunities Allc III is structured as a fund that invests substantially in other series within the GMO Trust. These underlying GMO Funds span a range of investment styles and asset classes, including Equity Funds, Fixed Income Funds, Implementation Funds, and Alternative Funds. The fund's investment strategy involves allocating capital across these diverse underlying funds to achieve its investment objectives. In addition to its investments in other GMO Funds, GMO Strategic Opportunities Allc III may directly employ derivatives and engage in short sales to enhance returns or hedge against potential risks. The fund's use of derivatives and short sales can occur either directly at the fund level or indirectly through its investments in the underlying GMO Funds. The fund aims to provide investors with exposure to a diversified portfolio of investment strategies managed by GMO, a well-established investment management firm. The fund's investment approach reflects GMO's overall investment philosophy and expertise across various asset classes and investment styles.
What Products and Services Does GBATX Offer?
- Invests in shares of other series of GMO Trust.
- Allocates assets across Equity Funds.
- Allocates assets across Fixed Income Funds.
- Allocates assets across Implementation Funds.
- Allocates assets across Alternative Funds.
- May invest in derivatives directly or through underlying funds.
- May effect short sales directly or through underlying funds.
How Does GBATX Make Money?
- Generates returns based on the performance of underlying GMO Funds.
- May enhance returns through the use of derivatives.
- May hedge against risks through short sales.
What Industry Does GBATX Operate In?
Due to the unknown sector and industry, it is difficult to provide a specific industry context. Generally, funds like GMO Strategic Opportunities Allc III operate within the broader asset management industry, which is influenced by market trends, interest rates, and investor sentiment. The competitive landscape includes other multi-asset funds and investment vehicles that offer diversified exposure across asset classes. The fund's performance is benchmarked against similar funds and its ability to generate returns relative to its risk profile.
Who Are GBATX's Key Customers?
- Institutional investors
- Financial advisors
- Individual investors seeking diversified investment solutions
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
GBATX Financials
Bull Case vs Bear Case
Bull Case
- Diversified exposure to various asset classes through underlying GMO Funds.
- Access to GMO's investment expertise and resources.
- Flexibility to use derivatives and short sales to enhance returns or hedge risks.
- Established track record of GMO Trust.
Bear Case
- Performance is heavily reliant on the performance of underlying GMO Funds.
- Use of derivatives and short sales can increase risk.
- Lack of direct control over the investment decisions of underlying funds.
- No dividend yield may not appeal to income-seeking investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GBATX Latest News
No recent news available for GBATX.
GBATX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GBATX.
Price Targets
Wall Street price target analysis for GBATX.
GBATX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GBATX; grades run from A+ (80-100) to F (below 30).
Investor Questions: GBATX Stock
What are the main risks for GBATX?
The main risks for GBATX include market volatility and economic downturns, which can negatively impact the performance of the underlying GMO Funds. The fund's dependence on the performance of these underlying funds is also a significant risk factor. Additionally, the use of derivatives and short sales can increase risk.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Data provided for informational purposes only.
- Information is based on limited available data.